DE69020257T2 - Nitrofurantoinkristalle. - Google Patents

Nitrofurantoinkristalle.

Info

Publication number
DE69020257T2
DE69020257T2 DE69020257T DE69020257T DE69020257T2 DE 69020257 T2 DE69020257 T2 DE 69020257T2 DE 69020257 T DE69020257 T DE 69020257T DE 69020257 T DE69020257 T DE 69020257T DE 69020257 T2 DE69020257 T2 DE 69020257T2
Authority
DE
Germany
Prior art keywords
particulates
nitrofurantoin
monohydrate
crystals
nitrofurantoin crystals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69020257T
Other languages
English (en)
Other versions
DE69020257D1 (de
Inventor
Frederick Dana Cazer
Barry Lee Scott
Michael John Kane
Vijay Shahi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Chilcott Pharmaceuticals Inc
Original Assignee
Norwich Eaton Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharmaceuticals Inc filed Critical Norwich Eaton Pharmaceuticals Inc
Publication of DE69020257D1 publication Critical patent/DE69020257D1/de
Application granted granted Critical
Publication of DE69020257T2 publication Critical patent/DE69020257T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE69020257T 1989-07-26 1990-07-18 Nitrofurantoinkristalle. Expired - Fee Related DE69020257T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US38605089A 1989-07-26 1989-07-26

Publications (2)

Publication Number Publication Date
DE69020257D1 DE69020257D1 (de) 1995-07-27
DE69020257T2 true DE69020257T2 (de) 1995-12-21

Family

ID=23523951

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69020257T Expired - Fee Related DE69020257T2 (de) 1989-07-26 1990-07-18 Nitrofurantoinkristalle.

Country Status (10)

Country Link
EP (1) EP0412592B1 (de)
AT (1) ATE124041T1 (de)
AU (1) AU641411B2 (de)
CA (1) CA2020813C (de)
DE (1) DE69020257T2 (de)
DK (1) DK0412592T3 (de)
ES (1) ES2073512T3 (de)
IE (1) IE67044B1 (de)
IL (1) IL95058A (de)
NZ (1) NZ234636A (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1231208A3 (de) * 1991-08-14 2003-12-10 Procter & Gamble Pharmaceuticals 4-Oxozyklische Harnstoffe, nützlich als antiarrhythmische und antifibrillatorische Wirkstoffe
KR101974412B1 (ko) 2018-02-28 2019-05-02 보령제약 주식회사 약학적 제제 및 이의 제조방법
CN110776499A (zh) * 2019-09-27 2020-02-11 济南金达药化有限公司 呋喃妥因一水合物晶体的制备方法以及呋喃妥因一水合物晶体

Also Published As

Publication number Publication date
IE67044B1 (en) 1996-02-21
AU641411B2 (en) 1993-09-23
ES2073512T3 (es) 1995-08-16
DK0412592T3 (da) 1995-08-14
IE902692A1 (en) 1991-02-27
IL95058A (en) 1995-03-30
IL95058A0 (en) 1991-06-10
NZ234636A (en) 1993-08-26
EP0412592B1 (de) 1995-06-21
DE69020257D1 (de) 1995-07-27
ATE124041T1 (de) 1995-07-15
AU5975390A (en) 1991-09-30
CA2020813C (en) 1995-08-01
EP0412592A1 (de) 1991-02-13

Similar Documents

Publication Publication Date Title
ES2064634T3 (es) Suspension farmaceutica acuosa para agentes activos farmaceuticos esencialmente insolubles en agua.
DE69032848T2 (de) Dosierungsmittel und dessen Verwendung
EP0815860A3 (de) Terfenadin-Carboxylat und die Behandlungvon allergischen Erkrankungen
DE68906746T2 (de) Psyllium enthaltende Produkte.
ATE172116T1 (de) Pharmazeutische anthocyanoside enthaltende zusammensetzungen zur oralen anwendung
HK1002019A1 (en) Pharmaceutical composition which contains a pharmaceutically suitable carrier and the compound having the structure (7alpha,17alpha)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-YN-3-one
CA2135709A1 (en) Melatonin derivatives for use in treating sleep disorders
DE69020257T2 (de) Nitrofurantoinkristalle.
EP0820771A3 (de) Arzneimittel zur Behandlung von Neuropathien, das ein lipidlösliches Thiamin und eine Magnesiumverbindung enthält
AU635948B2 (en) Liquid suspensions of nitrofurantoin
ITMI920760V0 (it) Struttura di utensile del tipo fresca o simile particolarmente per l'esecuzione di interventi chirurgici di implantologia odontoiatrica
ITMI941518A0 (it) Composizioni farmaceutiche per la prevenzione e/o il trattamento di disturbi gastrointestinali inclusa l'ulcera
ITMI942076A0 (it) Procedimento per la riduzione del contenuto di nicotina mediante l'azione di microrganismi
ITMI910442V0 (it) Struttura di zoccolo ortopedico, o simile, in particolare per la prevenzione o la cura del valgismo dell'alluce
CA2183764A1 (en) Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: PROCTER & GAMBLE PHARMACEUTICALS, NORWICH, N.Y., U

8339 Ceased/non-payment of the annual fee